XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.4
Cover - USD ($)
$ in Millions
 12 Months Ended
Sep. 30, 2024
Dec. 18, 2024
Mar. 28, 2024
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Financial Statement Error Correction [Flag] false    
Entity Interactive Data Current Yes    
ICFR Auditor Attestation Flag false    
Amendment Flag false    
Document Period End Date Sep. 30, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Documents Incorporated by Reference [Text Block]

Portions of the Company’s Proxy Statement for the Annual Meeting of Stockholders expected to be filed in January 2025 are incorporated by reference in Part III of this Report.

    
Entity Information [Line Items]      
Entity Registrant Name Citius Pharmaceuticals, Inc.    
Entity Central Index Key 0001506251    
Entity File Number 001-38174    
Entity Tax Identification Number 27-3425913    
Entity Incorporation, State or Country Code NV    
Current Fiscal Year End Date --09-30    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Shell Company false    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Public Float     $ 131,670,000
Entity Contact Personnel [Line Items]      
Entity Address, Address Line One 11 Commerce Drive    
Entity Address, Address Line Two First Floor    
Entity Address, City or Town Cranford    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07016    
Entity Phone Fax Numbers [Line Items]      
City Area Code (908)    
Local Phone Number 967-6677    
Entity Listings [Line Items]      
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol CTXR    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   7,727,243